Rendic S. Summary of information on human CYP enzymes: human P450 metabolism
data. Drug Metab Rev 2002;34:83–448.
Ross D. Quinone reductases. In: Guengerich FP, (editor). Biotransformation, Vol. 3,
Comprehensive Toxicology, first ed. Elsevier Science, Oxford; 1997. p 179–197.
Schlichting I, Berendzen J, Chu K, Stock AM, Maves SA, Benson DE, Sweet BM,
Ringe D, Petsko GA, Sligar SG. The catalytic pathway of cytochrome P450cam,at
atomic resolution. Science 2000;287:1615–1622.
Seto Y, Guengerich FP. Partitioning betweenN-dealkylation andN-oxygenation in the
oxidation ofN,N-dialkylarylamines catalyzed by cytochrome P450 2B1. J Biol Chem
1993;268:9986–9997.
Shaik S, Kumar D, de Visser SP, Altun A, Thiel W. Theoretical perspective on the
structure and mechanism of cytochrome P450 enzymes. Chem Rev 2005;105:2279–
2328.
Sinal CJ, Miyate M, Tohkin M, Nagata K, Bend JR, Gonzalez FJ. Targeted disruption
of soluble epoxide hydrolase reveals a role in blood pressure regulation. J Biol Chem
2000;275:40504–40510.
Sone T, Wang CY. Microsomal amidases and caraboxylesterases. In: Guengerich FP,
(editor). Biotransformation, Vol. 3, Comprehensive Toxicology. first ed. Elsevier
Science, Oxford; 1997. p 265–281.
Takimoto K, Lindahl R, Pitot HC. Regulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin-
inducible expression of aldehyde dehydrogenase in hepatoma cells. Arch Biochem
Biophys 1992;298:492–497.
Tzeng H-F, Laughlin LT, Lin S, Armstrong RN. The catalytic mechanism of
microsomal epoxide hydrolase involves reversible formation and rate-limiting
hydrolysis of the alkyl-enzyme intermediate. J Am Chem Soc 1996;118:9436–9437.
Van Houten KA, Kim JM, Bogdan MA, Feni DC, Mariano PS. A new strategy for the
design of monoamine oxidase inactivators. Exploratory studies with tertiary allylic
and propargylic amino alcohols. J Am Chem Soc 1998;120:5864–5872.
Vasiliou V, Nebert DW. Analysis and update of the human aldehyde dehydrogenase
(ALDH) gene family. Hum Genomic 2005;2:138–143.
Williams JA, Hyland R, Jones BC, Smith DA, Hust S, Goosen TC, Peterkin V, Koup
JR, Ball SE. Drug–drug interactions for UDP-glucuronosyltransferase substrates: a
pharmacokinetic explanation for typically observed low exposure (AUCi/AUC)
ratios. Drug Metab Dispos 2004;32:1201–1208.
Wislocki PG, Miwa GT, Lu AYH. Reactions catalyzed by the cytochrome P-450
system. In: Jakoby WB, (editor). Enzymatic Basis of Detoxication, Vol. I. first ed.
New York: Academic Press; 1980. p 135–182.
Wrighton SA, Stevens JC. The human hepatic cytochromes P450 involved in drug
metabolism. CRC Crit Rev Toxicol 1992;22:1–21.
Ziegler DM. Recent studies on the structure and function of multisubstrate flavin-
containing monooxygenases. Annu Rev Pharmacol Toxicol 1993;33:179–199.
Ziegler DM, Mitchell CH. Microsomal oxidase IV: properties of a mixed-function
amine oxidase isolated from pig liver microsomes. Arch Biochem Biophys 1972;
150:116–125.
REFERENCES 35